Home | FCA & regulatory news | British English edition
Trade Hub UK

Independent coverage of UK markets, FCA policy and institutional trading
AD Investing.com Markets AD LSEG Data AD CME Group Education AD Bank of England Statistics
Venues & MTFs

Freenome To Present Improved Precancerous Lesion Detection Data For CRC Blood Test

City noticeboard, Trade Hub UK (2026-10-12): Freenome To Present Improved Precancerous Lesion Detection Data For CRC Blood Test (RTTNews) - On Sunday, Freenome, Inc. (FRNM) said it will present new… Primary source: original at Nasdaq Market Structure (nasdaq.com).

By Nasdaq Market Structure

Freenome To Present Improved Precancerous Lesion Detection Data For CRC Blood Test

(RTTNews) - On Sunday, Freenome, Inc. (FRNM) said it will present new clinical validation data for an updated version of its SimpleScreen colorectal cancer (CRC) blood-based screening test at the American College of Gastroenterology (ACG) 2026 Annual Meeting in Nashville.

Read at source

Read also
  1. Cerebras Is About as Big as Nvidia's Data Center Business Was Nearly a Decade Ago. The Similarities Mostly End There.
  2. Beyond S&P 500 Index Funds: Here's the 1 Sector I'd Buy First as a New Investor
  3. Stocks Settle Higher on Earnings Optimism
  4. Adobe's Earnings Are on Track to Grow About Eightfold in a Decade. Why Has Its Stock Lagged the Market So Badly?
  5. Excited About Social Security's Upcoming COLA Announcement? That's Not the Only Change Set to Be Revealed Next Week

Source: Nasdaq Market Structure